{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:04:07Z","timestamp":1788397447290,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00213-013-3382-4","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T04:05:37Z","timestamp":1386907537000},"page":"319-325","source":"Crossref","is-referenced-by-count":87,"title":["Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug na\u00efve, first-episode schizophrenia"],"prefix":"10.1007","volume":"231","author":[{"given":"Xueqin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoduo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Ziedonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"key":"3382_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-013-3199-1","volume":"230","author":"A Amrami-Weizman","year":"2013","unstructured":"Amrami-Weizman A, Maayan R, Gil-Ad I, Pashinian A, Fuchs C, Kotler M, Poyurovsky M (2013) The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients. Psychopharmacology (Berlin) 230:23\u201327","journal-title":"Psychopharmacology (Berlin)"},{"key":"3382_CR2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/sj.ijo.0803306","volume":"30","author":"JI Barzilay","year":"2006","unstructured":"Barzilay JI, Forsberg C, Heckbert SR, Cushman M, Newman AB (2006) The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study. Int J Obes (London) 30:1362\u20131367","journal-title":"Int J Obes (London)"},{"key":"3382_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/0269881112473789","volume":"27","author":"CJ Bushe","year":"2013","unstructured":"Bushe CJ, Slooff CJ, Haddad PM, Karagianis JL (2013) Weight change by baseline BMI from 3-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database. J Psychopharmacol 27:358\u2013365, Oxford, England","journal-title":"J Psychopharmacol"},{"key":"3382_CR4","first-page":"1","volume":"17","author":"C Chen","year":"2004","unstructured":"Chen C, Lu FC, Department of Disease Control Ministry of Health, P.R.C. (2004) The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci: BES 17:1\u201336","journal-title":"Biomed Environ Sci: BES"},{"key":"3382_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11481-012-9382-z","volume":"7","author":"SL Chen","year":"2012","unstructured":"Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, Tzeng NS, Lee IH, Chen PS, Yeh TL, Huang SY, Yang YK, Lu RB, Hong JS (2012) Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan. J Neuroimmune Pharm 7:656\u2013664","journal-title":"J Neuroimmune Pharm"},{"key":"3382_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","volume":"221","author":"KJ Davey","year":"2012","unstructured":"Davey KJ, O'Mahony SM, Schellekens H, O'Sullivan O, Bienenstock J, Cotter PD, Dinan TG, Cryan JF (2012) Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berlin) 221:155\u2013169","journal-title":"Psychopharmacology (Berlin)"},{"key":"3382_CR7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","volume":"20","author":"L Drzyzga","year":"2006","unstructured":"Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS (2006) Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20:532\u2013545","journal-title":"Brain Behav Immun"},{"key":"3382_CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0278-5846(93)90072-Z","volume":"17","author":"RS el-Mallakh","year":"1993","unstructured":"el-Mallakh RS, Suddath RL, Wyatt RJ (1993) Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 17:383\u2013391","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3382_CR9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/14737175.7.7.789","volume":"7","author":"X Fan","year":"2007","unstructured":"Fan X, Goff DC, Henderson DC (2007) Inflammation and schizophrenia. Expert Rev Neurother 7:789\u2013796","journal-title":"Expert Rev Neurother"},{"key":"3382_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/acps.12009","volume":"127","author":"X Fan","year":"2013","unstructured":"Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC (2013) Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand 127:217\u2013226","journal-title":"Acta Psychiatr Scand"},{"key":"3382_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2011.05.010","volume":"190","author":"MH Fawzi","year":"2011","unstructured":"Fawzi MH, Fawzi MM, Fawzi MM, Said NS (2011) C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiatry Res 190:91\u201397","journal-title":"Psychiatry Res"},{"key":"3382_CR12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","volume":"73","author":"AM Fineberg","year":"2013","unstructured":"Fineberg AM, Ellman LM (2013) Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry 73:951\u2013966","journal-title":"Biol Psychiatry"},{"key":"3382_CR13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/sj.npp.1300217","volume":"28","author":"DL Garver","year":"2003","unstructured":"Garver DL, Tamas RL, Holcomb JA (2003) Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 28:1515\u20131520","journal-title":"Neuropsychopharmacology"},{"key":"3382_CR14","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/oby.2010.73","volume":"18","author":"T Holz","year":"2010","unstructured":"Holz T, Thorand B, Doring A, Schneider A, Meisinger C, Koenig W (2010) Markers of inflammation and weight change in middle-aged adults: results from the prospective MONICA\/KORA S3\/F3 study. Obesity 18:2347\u20132353, Silver Spring, Md","journal-title":"Obesity"},{"key":"3382_CR15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860\u2013867","journal-title":"Nature"},{"key":"3382_CR16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","volume":"219","author":"G Jassim","year":"2012","unstructured":"Jassim G, Skrede S, Vazquez MJ, Wergedal H, Vik-Mo AO, Lunder N, Dieguez C, Vidal-Puig A, Berge RK, Lopez M, Steen VM, Ferno J (2012) Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berlin) 219:783\u2013794","journal-title":"Psychopharmacology (Berlin)"},{"key":"3382_CR17","doi-asserted-by":"crossref","unstructured":"Kemp DE, Correll CU, Tohen M, Delbello MP, Ganocy SJ, Findling RL, Chang K (2013) Associations Among Obesity, Acute Weight Gain, and Response to Treatment with Olanzapine in Adolescent Schizophrenia. J Child Adolesc Psychopharmacol","DOI":"10.1089\/cap.2012.0099"},{"key":"3382_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000213565","volume":"59","author":"YK Kim","year":"2009","unstructured":"Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B (2009) Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology 59:123\u2013129","journal-title":"Neuropsychobiology"},{"key":"3382_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0269881111431622","volume":"26","author":"BE Leonard","year":"2012","unstructured":"Leonard BE, Schwarz M, Myint AM (2012) The metabolic syndrome in schizophrenia: is inflammation a contributing cause? J Psychopharmacol 26:33\u201341, Oxford, England","journal-title":"J Psychopharmacol"},{"key":"3382_CR20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1176\/ajp.150.9.1408","volume":"150","author":"J Licinio","year":"1993","unstructured":"Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH (1993) Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry 150:1408\u20131410","journal-title":"Am J Psychiatry"},{"key":"3382_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(98)00034-6","volume":"32","author":"A Lin","year":"1998","unstructured":"Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, Pioli R, Altamura C, Scharpe S, Maes M (1998) The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res 32:9\u201315","journal-title":"Schizophr Res"},{"key":"3382_CR22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.psychres.2012.05.036","volume":"200","author":"I Martinez-Gras","year":"2012","unstructured":"Martinez-Gras I, Garcia-Sanchez F, Guaza C, Rodriguez-Jimenez R, Andres-Esteban E, Palomo T, Rubio G, Borrell J (2012) Altered immune function in unaffected first-degree biological relatives of schizophrenia patients. Psychiatry Res 200:1022\u20131025","journal-title":"Psychiatry Res"},{"key":"3382_CR23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2009.06.005","volume":"66","author":"JM Meyer","year":"2009","unstructured":"Meyer JM, McEvoy JP, Davis VG, Goff DC, Nasrallah HA, Davis SM, Hsiao JK, Swartz MS, Stroup TS, Lieberman JA (2009) Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biol Psychiatry 66:1013\u20131022","journal-title":"Biol Psychiatry"},{"key":"3382_CR24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663\u2013671","journal-title":"Biol Psychiatry"},{"key":"3382_CR25","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbi.2011.05.005","volume":"25","author":"AM Myint","year":"2011","unstructured":"Myint AM, Schwarz MJ, Verkerk R, Mueller HH, Zach J, Scharpe S, Steinbusch HW, Leonard BE, Kim YK (2011) Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients. Brain Behav Immun 25:1576\u20131581","journal-title":"Brain Behav Immun"},{"key":"3382_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000111535","volume":"56","author":"KS Na","year":"2007","unstructured":"Na KS, Kim YK (2007) Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 56:55\u201363","journal-title":"Neuropsychobiology"},{"key":"3382_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0920-9964(97)00059-5","volume":"26","author":"J Naudin","year":"1997","unstructured":"Naudin J, Capo C, Giusano B, Mege JL, Azorin JM (1997) A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res 26:227\u2013233","journal-title":"Schizophr Res"},{"key":"3382_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2006.02.003","volume":"84","author":"SO Nunes","year":"2006","unstructured":"Nunes SO, Matsuo T, Kaminami MS, Watanabe MA, Reiche EM, Itano EN (2006) An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives. Schizophr Res 84:180\u2013182","journal-title":"Schizophr Res"},{"key":"3382_CR29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psychres.2007.11.014","volume":"160","author":"SM O'Brien","year":"2008","unstructured":"O'Brien SM, Scully P, Dinan TG (2008) Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res 160:256\u2013262","journal-title":"Psychiatry Res"},{"key":"3382_CR30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.1230721","volume":"339","author":"JI Odegaard","year":"2013","unstructured":"Odegaard JI, Chawla A (2013) Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339:172\u2013177","journal-title":"Science"},{"key":"3382_CR31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-012-2850-6","volume":"225","author":"JJ Ou","year":"2013","unstructured":"Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J, Guo XF, Wu RR, Zhao JP (2013) Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Psychopharmacology (Berlin) 225:627\u2013635","journal-title":"Psychopharmacology (Berlin)"},{"key":"3382_CR32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","volume":"16","author":"T Pollmacher","year":"1996","unstructured":"Pollmacher T, Hinze-Selch D, Mullington J (1996) Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 16:403\u2013409","journal-title":"J Clin Psychopharmacol"},{"key":"3382_CR33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801\u2013808","journal-title":"Biol Psychiatry"},{"key":"3382_CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(97)00008-X","volume":"25","author":"MH Rapaport","year":"1997","unstructured":"Rapaport MH, McAllister CG, Pickar D, Tamarkin L, Kirch DG, Paul SM (1997) CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers. Schizophr Res 25:123\u2013129","journal-title":"Schizophr Res"},{"key":"3382_CR35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","volume":"17","author":"SA Ritchie","year":"2007","unstructured":"Ritchie SA, Connell JM (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis: NMCD 17:319\u2013326","journal-title":"Nutr Metab Cardiovasc Dis: NMCD"},{"key":"3382_CR36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000067807","volume":"46","author":"S Rudolf","year":"2002","unstructured":"Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H (2002) The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro. Neuropsychobiology 46:180\u2013185","journal-title":"Neuropsychobiology"},{"key":"3382_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10401239409149001","volume":"6","author":"BS Runeson","year":"1994","unstructured":"Runeson BS, Rich CL (1994) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. (DSM-III), adaptive functioning in young Swedish suicides. Ann Clin Psychiatry: Off J Am Acad Clin Psychiatr 6:181\u2013183","journal-title":"Ann Clin Psychiatry: Off J Am Acad Clin Psychiatr"},{"key":"3382_CR38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1006\/jaut.1996.0086","volume":"9","author":"A Schattner","year":"1996","unstructured":"Schattner A, Cori Y, Hahn T, Sirota P (1996) No evidence for autoimmunity in schizophrenia. J Autoimmun 9:661\u2013666","journal-title":"J Autoimmun"},{"key":"3382_CR39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","volume":"65","author":"XQ Song","year":"2009","unstructured":"Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP (2009) The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol Psychiatry 65:481\u2013488","journal-title":"Biol Psychiatry"},{"key":"3382_CR40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fendo.2013.00093","volume":"4","author":"S Tateya","year":"2013","unstructured":"Tateya S, Kim F, Tamori Y (2013) Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) 4:93","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3382_CR41","first-page":"601534","volume":"2013","author":"S Vasunilashorn","year":"2013","unstructured":"Vasunilashorn S (2013) Retrospective reports of weight change and inflammation in the US National Health and Nutrition Examination Survey. J Obes 2013:601534","journal-title":"J Obes"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3382-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3382-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T17:36:54Z","timestamp":1564940214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3382-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,14]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["3382"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3382-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718207213.793492437","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,14]]}}}